These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 3834952

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P, Madgelenat H, Jouve M, Palangie T, Garcia-Giralt E, Bretaudeau B, Polijcak M, Asselain B.
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [Abstract] [Full Text] [Related]

  • 24. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
    Pewnim T, Adams JB, Ho KP.
    Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
    [Abstract] [Full Text] [Related]

  • 25. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovács A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2008 Mar 20; 26(9):1404-10. PubMed ID: 18349391
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
    Ferrer Roca OF, Ramos A, Diaz Cardama A.
    Anal Cell Pathol; 1995 Sep 20; 9(2):151-63. PubMed ID: 7492518
    [Abstract] [Full Text] [Related]

  • 30. Steroid hormone receptors in the management of human breast cancer.
    Knight WA, Osborne CK, Yochmowitz MG, McGuire WL.
    Ann Clin Res; 1980 Oct 20; 12(5):202-7. PubMed ID: 7015982
    [Abstract] [Full Text] [Related]

  • 31. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
    Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thürlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.
    J Clin Oncol; 2007 Sep 01; 25(25):3846-52. PubMed ID: 17679725
    [Abstract] [Full Text] [Related]

  • 32. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L, Salazar EL, Pedron Nuevo N.
    Ginecol Obstet Mex; 1996 Mar 01; 64():135-9. PubMed ID: 8729191
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Stimulation of human peripheral blood lymphocytes by Tamm-Horsfall urinary glycoprotein.
    Hunt JS, McGiven AR.
    Immunology; 1978 Aug 01; 35(2):391-5. PubMed ID: 750375
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
    Jalava P, Kuopio T, Huovinen R, Laine J, Collan Y.
    Anticancer Res; 2005 Aug 01; 25(3c):2535-42. PubMed ID: 16080489
    [Abstract] [Full Text] [Related]

  • 36. [Relation between grades of histologic differentiation and hormone receptors in breast cancer].
    Nola N, Separović V, Sarcević B, Graf D, Petrinec Z, Matesa N, Kruslin B.
    Lijec Vjesn; 1995 Aug 01; 117(5-6):117-20. PubMed ID: 8600322
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition and potentiation of T lymphocyte response to mitogens. Studies using two mitogenic stimuli simultaneously.
    Franceschi C, Cevolani C, Licastro F, Paolucci P, Prodi G, Perocco P.
    Arch Sci Biol (Bologna); 1978 Aug 01; 62(1-4):139-54. PubMed ID: 400233
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.